Fredun Pharmaceuticals Limited (NSE:FREDUN)

Fredun Pharmaceuticals Revenue

Fredun Pharmaceuticals had revenue of 2.68B INR in the quarter ending September 30, 2026, with 86.39% growth. This brings the company's total for the last twelve months to 8.66B, up 63.24% year-over-year. In the fiscal year ending March 31, 2026, Fredun Pharmaceuticals had annual revenue of 6.35B with 40.03% growth.

• Revenue (ttm): 8.66B
• Revenue Growth: +63.24%
• P/S Ratio: 2.90
• Revenue / Employee: 11.77M
• Employees: 736
• Market Cap: 25.12B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• India 5.26B 83.1%
• export 1.07B 16.9%

Fiscal year ended Mar 31, 2026 See the full Fredun Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	6.35B	1.82B	40.03%
Mar 31, 2025	4.54B	1.06B	30.35%
Mar 31, 2024	3.48B	734.81M	26.75%
Mar 31, 2023	2.75B	502.16M	22.37%
Mar 31, 2022	2.24B	906.43M	67.74%

Data Source: S&P Global Market Intelligence Last updated: Nov 5, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 6, 2026

Data Sources Report a data error